Breaking News Instant updates and real-time market news.

ALXN

Alexion

$119.68

1.31 (1.11%)

17:24
08/14/18
08/14
17:24
08/14/18
17:24

Alexion files to sell 8.49M shares of common stock for holders

ALXN Alexion
$119.68

1.31 (1.11%)

06/15/18
OPCO
06/15/18
NO CHANGE
OPCO
Outperform
Large-cap biotech fundamentals slowly improving, says Oppenheimer
Ahead of Q2 biotech earnings starting in mid-July, Oppenheimer analyst Hartaj Singh tells investors in a research note that large-cap fundamentals and sector sentiment are "slowly but surely" improving. Improving fundamentals indicate that large-cap biotech results could outperform in Q2, with Gilead (GILD), Alexion (ALXN) and Vertex (VRTX) leading the charge. Singh called out Vertex as "one of our favorite large-cap biotech names," and also says he believes the negative sentiment around Regeneron (REGN) "might be peaking." Singh, who has Outperform ratings on Alexion and Vertex and a Perform rating on Gilead and Regeneron, says he is "cautiously bullish" on the sector.
07/26/18
EVER
07/26/18
NO CHANGE
Target $158
EVER
Outperform
Alexion price target raised to $158 from $150 at Evercore ISI
Evercore ISI analyst Josh Schimmer said Alexion is "consistently conservative" on guidance and he wouldn't be surprised to see the company raise its outlook again in Q3 as it did with its Q2 report. He also noted that company reported "slight" delays for 1210 and its Wilson's program. Following the report, he raised his price target on Alexion to $158 and reiterated his Outperform rating on the shares.
07/26/18
PIPR
07/26/18
NO CHANGE
PIPR
Piper Jaffray would be buyers on Alexion weakness
Piper Jaffray analyst Christopher Raymond said in a research note that he believes the pressure in Alexion is "more macro-driven than company specific." He noted that with a solid Q2 beat and FY18 raise, along with continued pipeline progress and increased certainty with regard to the complement inhibition franchise's revenue tail, there is much to like with this name, and he would recommend buying the name on weakness. He kept an Overweight rating and $170 price target on Alexion shares.
08/07/18
STFL
08/07/18
DOWNGRADE
Target $130
STFL
Hold
Alexion downgraded to Hold from Buy at Stifel
Stifel transferred coverage of Alexion to analyst Paul Matteis, who set a Hold rating and $130 price target on the shares, down from the firm's prior Buy rating. He has difficulty envisioning significant upside to mid-to-long-term consensus expectations given his worries about the risks associated with an increasingly challenging European payor environment and the breadth of drug development ongoing in the complement space, Matteis tells investors.

TODAY'S FREE FLY STORIES

10:25
12/13/18
12/13
10:25
12/13/18
10:25
General news
Today's U.S. reports »

Today's U.S. reports…

10:21
12/13/18
12/13
10:21
12/13/18
10:21
Conference/Events
JPMorgan Internet analyst to hold an analyst/industry conference call »

Internet Analyst Anmuth…

10:19
12/13/18
12/13
10:19
12/13/18
10:19
Conference/Events
JPMorgan household/personal care analysts hold analyst/industry conference call »

Household & Personal…

SMTC

Semtech

$48.38

0.14 (0.29%)

10:17
12/13/18
12/13
10:17
12/13/18
10:17
Conference/Events
Semtech management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/13/18
12/13
10:17
12/13/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$7.38

0.66 (9.82%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
On The Fly
General Electric jumps as long-time bear ups rating after two and a half years »

Shares of General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIA

Saia

$55.48

0.175 (0.32%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
Conference/Events
Saia management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 20

    Dec

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/13/18
12/13
10:16
12/13/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGI

Alamos Gold

$3.22

-0.19 (-5.57%)

10:15
12/13/18
12/13
10:15
12/13/18
10:15
Downgrade
Alamos Gold rating change  »

Alamos Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/13/18
12/13
10:15
12/13/18
10:15
General news
Breaking General news story  »

Week of 12/7 EIA Natural…

MAC

Macerich

$49.36

2.23 (4.73%)

, SPG

Simon Property

$184.56

2.05 (1.12%)

10:14
12/13/18
12/13
10:14
12/13/18
10:14
Hot Stocks
Macerich up after Dealreporter speculates on renewed Simon deal interest »

Dealreporter noted that…

MAC

Macerich

$49.36

2.23 (4.73%)

SPG

Simon Property

$184.56

2.05 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.49

-0.04 (-0.16%)

10:10
12/13/18
12/13
10:10
12/13/18
10:10
Options
One-day upside call spread seller in Bank of America »

One-day upside call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

MGLN

Magellan Health

$60.63

2 (3.41%)

10:07
12/13/18
12/13
10:07
12/13/18
10:07
Periodicals
Starboard to push Magellan to improve or sell itself, Bloomberg reports »

Jeff Smith's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:05
12/13/18
12/13
10:05
12/13/18
10:05
General news
Treasury Option Action: put positioning in the belly »

Treasury Option Action:…

10:05
12/13/18
12/13
10:05
12/13/18
10:05
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

ROKU

Roku

$35.30

0.1301 (0.37%)

10:05
12/13/18
12/13
10:05
12/13/18
10:05
Conference/Events
Roku management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 18

    Dec

  • 19

    Dec

CTIC

CTI BioPharma

$1.49

(0.00%)

10:04
12/13/18
12/13
10:04
12/13/18
10:04
Hot Stocks
CTI BioPharma to cut approx. 50% of total workforce in restructuring »

CTI BioPharma announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,075.83

12.27 (1.15%)

, GOOGL

Alphabet Class A

$1,085.00

11.34 (1.06%)

10:04
12/13/18
12/13
10:04
12/13/18
10:04
Periodicals
Google employees instructed to treat TVCs differently, The Guardian reports »

Google employees are…

GOOG

Alphabet

$1,075.83

12.27 (1.15%)

GOOGL

Alphabet Class A

$1,085.00

11.34 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

TSLA

Tesla

$367.70

0.94 (0.26%)

10:04
12/13/18
12/13
10:04
12/13/18
10:04
On The Fly
Analyst sees narrative around Tesla changing as Wired reports on 'rage firings' »

Shares of Tesla (TSLA)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MGLN

Magellan Health

$61.38

2.75 (4.69%)

10:03
12/13/18
12/13
10:03
12/13/18
10:03
Hot Stocks
Magellan rallies after activist Starboard discloses nearly 10% stake »

Jeff Smith's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$20.67

-0.57 (-2.68%)

10:01
12/13/18
12/13
10:01
12/13/18
10:01
Upgrade
TechnipFMC rating change  »

BMO Capital says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

PYPL

PayPal

$88.01

1.51 (1.75%)

10:01
12/13/18
12/13
10:01
12/13/18
10:01
Conference/Events
PayPal management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 13

    Dec

  • 18

    Dec

OXM

Oxford Industries

$67.67

-7.21 (-9.63%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
Oxford Industries falls -9.0% »

Oxford Industries is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$58.45

-6.2 (-9.59%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -9.8% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$14.56

-5.6 (-27.78%)

10:00
12/13/18
12/13
10:00
12/13/18
10:00
Hot Stocks
Tailored Brands falls -27.5% »

Tailored Brands is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.